Clinical trials recruiting in Butler, Pennsylvania
12
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 5Phase 3 7Not applicable 3
Conditions recruiting in Butler, Pennsylvania
Recruiting trials in Butler, Pennsylvania
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Common questions
How many clinical trials are recruiting in Butler, Pennsylvania?
12 recruiting trials have at least one study site in Butler, Pennsylvania.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.